Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDC documents library

Executive Summary

Recent additions to F-D-C Reports' document library include the Senate Finance Committee FDL-1letter to drug companies seeking information on educational grants, the HHS FDL-2Inspector General Office letter to Senate Health Committee Chairman Mike Enzi (R-Wyo.) regarding personal conduct allegations about FDA Commissioner nominee Lester Crawford, a federal FDL-3Appeals Court ruling and FDL-4District Court ruling on "authorized" generics in Teva v. Crawford, and FDA's letter approving FDL-5Pfizer's Revatio for pulmonary arterial hypertension to improve exercise ability. Sign up for a free twice-monthly email alert to new documents at 1http://www.fdcreports.com/documentsalert and browse documents at 2http://www.fdcreports.com/documents...

Recent additions to F-D-C Reports' document library include the Senate Finance Committee FDL-1 letter to drug companies seeking information on educational grants, the HHS FDL-2 Inspector General Office letter to Senate Health Committee Chairman Mike Enzi (R-Wyo.) regarding personal conduct allegations about FDA Commissioner nominee Lester Crawford, a federal FDL-3 Appeals Court ruling and FDL-4 District Court ruling on "authorized" generics in Teva v. Crawford, and FDA's letter approving FDL-5 Pfizer's Revatio for pulmonary arterial hypertension to improve exercise ability. Sign up for a free twice-monthly email alert to new documents at 1 http://www.fdcreports.com/documentsalert and browse documents at 2 http://www.fdcreports.com/documents....

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS045928

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel